Trinity Biotech Shares Are Trading Higher After the Company Announced the Acquisition of EpiCapture. Also the Company Announced a Strategic Investment in Novus Diagnostics to Advance Development and Commercialization of Novus' Point-of-care Diagnostic...

trinity biotech宣佈併購EpiCapture後，其股價有所上漲。另外，該公司還宣佈對Novus Diagnostics進行戰略投資，以推動Novus點對點診斷的發展和商業化...

Benzinga · 10/25 20:47

Trinity Biotech Shares Are Trading Higher After the Company Announced the Acquisition of EpiCapture. Also the Company Announced a Strategic Investment in Novus Diagnostics to Advance Development and Commercialization of Novus' Point-of-care Diagnostic Solutions.

trinity biotech股價上漲，因該公司宣佈收購EpiCapture。此外，該公司還宣佈對Novus Diagnostics進行戰略投資，以推動Novus的即時診斷解決方案的發展和商業化。

譯文內容由第三人軟體翻譯。

以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。